CVS Health and Aetna in June 2018 announced their post-merger leadership team. Aetna President Karen Lynch will stay on as executive vice president of CVS and president of the Aetna business unit. Richard di Benedetto will continue in his current role as president of Aetna International. Shawn Guertin, Aetna’s CFO and chief enterprise risk officer, will become executive vice president and CFO of CVS. Fran Soistman, executive vice president
Three months after the December 2017 announcement that CVS Health had purchased Aetna, their respective shareholders on March 13, 2018 voted to approve the proposed $69 billion merger of the companies at special meetings. As discussed in an earlier post, the acquisition sets the stage for a new type of company that will include a health insurer, a retail pharmacy, and a pharmacy benefits manager that negotiates prescription drug
The announcement that CVS plans to acquire Aetna for US$69 billion raises hope and concerns. The transaction would create a new health care giant. Aetna is the third-largest health insurer in the United States, insuring about 46.7 million people.
The announcement that CVS Health has purchased Aetna, referred to in our earlier news item, was made on Sunday, 4 December 2017, laying to rest months of rumor and speculation. The acquisition sets the stage for a new type of company that will include a health insurer, a retail pharmacy, and a pharmacy benefits manager that negotiates prescription drug prices with drug-makers. The announcement comes at a time when
CVS Health, an American drug store chain that also operates walk-in health clinics and a pharmacy benefit business, in October 2017 was reported to be in talks to purchase Aetna Insurance in a deal that could be worth more than $60 billion based on Aetna’s current market value. This would make the purchase one of the largest in the history of the health industry. CVS, with the addition of